Mark Mortenson
About Mark Mortenson
Mark Mortenson - Chief Science Officer
Mark Mortenson serves as the Chief Science Officer at Clene. In this role, he is responsible for leading scientific research and development initiatives. Mark's contributions include co-inventing the technology platform for producing Clene’s Clean-Surface Nanocrystal (CSN™) therapeutics.
Co-inventor of Clean-Surface Nanocrystal (CSN™) Therapeutics
Mark Mortenson is the co-inventor of the technology platform developed to produce Clene’s Clean-Surface Nanocrystal (CSN™) therapeutics. This innovative technology aims to create more effective treatments and represents a significant advancement in the therapeutic use of nanocrystals.
Mark Mortenson - Patent Portfolio
Mark Mortenson is an inventor or co-inventor on 30 U.S. patents and holds hundreds of corresponding foreign patents. He has a background as a chief patent counsel, where he was responsible for the management of approximately 5,500 patents and patent applications in the U.S. and 44 foreign countries.
Mark Mortenson's Education and Expertise
Mark Mortenson holds a Bachelor of Science in physics and a Bachelor of Science in ceramic engineering from Alfred University. He furthered his education with a Master of Science in material science from Pennsylvania State University. Additionally, he earned a Juris Doctor degree from George Washington University.
Former COO of Research, Development and Manufacturing
Before his current role, Mark Mortenson served as the Chief Operating Officer of Research, Development, and Manufacturing at an advanced materials-based company with more than 300 employees. In this position, he managed significant R&D and manufacturing processes.